Gain of Function of a p53 Hot Spot Mutation in a Mouse Model of Li-Fraumeni Syndrome
Top Cited Papers
- 17 December 2004
- journal article
- Published by Elsevier BV in Cell
- Vol. 119 (6), 861-872
- https://doi.org/10.1016/j.cell.2004.11.006
Abstract
No abstract availableThis publication has 51 references indexed in Scilit:
- Mutation at p53 serine 389 does not rescue the embryonic lethality in mdm2 or mdm4 null miceOncogene, 2004
- Drug discovery and p53Drug Discovery Today, 2003
- Novel gain of function activity of p53 mutants: activation of the dUTPase gene expression leading to resistance to 5-fluorouracilOncogene, 2002
- p63 and p73 are required for p53-dependent apoptosis in response to DNA damageNature, 2002
- A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core DomainMolecular and Cellular Biology, 2001
- Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53Oncogene, 2001
- Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesisOncogene, 1998
- A transgenic mouse model for mammary carcinogenesisOncogene, 1998
- The Li-Fraumeni syndrome: An inherited susceptibility to cancerMolecular Medicine Today, 1997
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994